Starlineps to acquire 50% stake in Celloraa Energy for Rs 160 Crore

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹10.63

prior close

₹11.16

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%+4.0% vs market

Metals & Minerals Trading peers, median of 12sector · industry level-0.4%+5.4% vs sector

On the reaction day the stock moved 4.0 pts more than Nifty Microcap 250 and 5.4 pts more than its Metals & Minerals Trading peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0+1.0+4.0-0.4+5.4

Next day

+7.1+1.2+5.9+0.3+6.7

+5.2+2.1+3.1+0.2+5.0

+4.7+1.7+3.0+0.3+4.5

+2.4+1.9+0.5+2.4+0.0

+0.8+1.2-0.4+0.2+0.6

+0.4+1.1-0.7-0.2+0.5

15d

-0.8+1.6-2.5+2.5-3.3

-6.0+0.1-6.1+0.9-6.9

-17.7+6.6-24.3-3.5-14.2

-23.8+5.5-29.3-2.4-21.4

UpDownMarket · Nifty Microcap 250Sector · Metals & Minerals Trading peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Starlineps Enterprises board approved acquiring 50% equity stake in Celloraa Energy Private Limited for Rs 160 Crore via cash, at Rs 64,000 per share. Celloraa is setting up a 1.2 GW solar cell manufacturing facility using German technology and plans to expand to 2.4 GW. The target was incorporated in February 2026 and has NIL turnover so far. Deal is subject to shareholder and regulatory approvals, expected to complete within 12 months.

Likely market impact

Diversification into solar cell manufacturing with a large cash outlay. Target is pre-revenue with execution risk and needs shareholder approval.